RG

Renu Gupta

Active Director Director DIN 03417571
DIN 03417571 First appointment May 2011 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2011
Shareholding value •••• Premium profile

About Renu Gupta

Data last updated:

Renu Gupta is a Director at Jeevan Jyoti Medilife Private Limited (since 2011). The company operates in Professional Services. Jeevan Jyoti Medilife Private Limited reported revenue of ₹97 Lakh (FY 2025).

DIN 03417571
Primary Designation Director
Industry Professional Services
First Appointment 05 May 2011
Oldest Company Age 15 yrs
Largest company Jeevan Jyoti Medilife Private Limited · ₹97 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 May 20112011₹97 Lakh (FY 2025)Active

Board colleagues of Renu Gupta

Directorship timeline

Open interactive timeline →
Jeevan Jyoti Medilife Private Limited
Premium access

Shareholding and investment profile for Renu Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Gupta

Renu Gupta currently holds 1 directorship: Jeevan Jyoti Medilife Private Limited (Director, since 05 May 2011, revenue ₹97 Lakh (FY 2025)).

Renu Gupta was first appointed on 05 May 2011 as Director at Jeevan Jyoti Medilife Private Limited.

The current boards of Renu Gupta's companies include Dhananjay Prasad (Jeevan Jyoti Medilife Private Limited), Poonam Gupta (Jeevan Jyoti Medilife Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available